Used as a selective agonist for group II metabotropic glutamate receptors (mGluR2 and mGluR3) in neuroscience research. It helps study glutamatergic neurotransmission and modulate synaptic activity. Due to its ability to cross the blood-brain barrier more effectively than other analogs, it is valuable in in vivo studies investigating anxiety, schizophrenia, and neurodegenerative disorders. Also employed in structure-activity relationship studies to develop new neuroactive compounds.